Michael Steinberg

651 total citations
21 papers, 476 citations indexed

About

Michael Steinberg is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Steinberg has authored 21 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Steinberg's work include Hematopoietic Stem Cell Transplantation (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neutropenia and Cancer Infections (3 papers). Michael Steinberg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Neutropenia and Cancer Infections (3 papers). Michael Steinberg collaborates with scholars based in United States, Netherlands and Switzerland. Michael Steinberg's co-authors include Matthew J. Silva, Anna K. Morin, M. R. Cooper, Miguel Islas‐Ohlmayer, Julie A. Murphy, Kurt Winkler, Jeffrey Matous, Paul Shaughnessy, Peter A. McSweeney and Michael B. Maris and has published in prestigious journals such as Blood, Clinical Therapeutics and Annals of Pharmacotherapy.

In The Last Decade

Michael Steinberg

21 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Steinberg United States 12 197 141 97 68 54 21 476
Tusar Giri United States 16 168 0.9× 55 0.4× 79 0.8× 64 0.9× 100 1.9× 35 599
David P. Sheridan Canada 13 157 0.8× 102 0.7× 265 2.7× 105 1.5× 90 1.7× 32 687
Eveline de Bont Netherlands 8 227 1.2× 77 0.5× 133 1.4× 147 2.2× 34 0.6× 11 568
Philip A. DeSimone United States 7 165 0.8× 161 1.1× 118 1.2× 55 0.8× 11 0.2× 16 618
Wei‐Sheng Huang Taiwan 8 172 0.9× 61 0.4× 100 1.0× 118 1.7× 14 0.3× 16 399
Sarah S. Burns United States 15 72 0.4× 85 0.6× 167 1.7× 55 0.8× 29 0.5× 28 468
Duncan R. Forsyth United Kingdom 9 277 1.4× 28 0.2× 180 1.9× 168 2.5× 36 0.7× 16 547
Klára Gadó Hungary 9 106 0.5× 88 0.6× 102 1.1× 26 0.4× 62 1.1× 30 313
Martin Vogelhuber Germany 16 54 0.3× 288 2.0× 158 1.6× 39 0.6× 44 0.8× 50 600
William Roberts United States 16 60 0.3× 89 0.6× 209 2.2× 55 0.8× 32 0.6× 38 563

Countries citing papers authored by Michael Steinberg

Since Specialization
Citations

This map shows the geographic impact of Michael Steinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Steinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Steinberg more than expected).

Fields of papers citing papers by Michael Steinberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Steinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Steinberg. The network helps show where Michael Steinberg may publish in the future.

Co-authorship network of co-authors of Michael Steinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Steinberg. A scholar is included among the top collaborators of Michael Steinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Steinberg. Michael Steinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steinberg, Michael, et al.. (2020). A Collaborative Survey of Nurse Practitioner Colorectal Cancer Screening Practice. The Journal for Nurse Practitioners. 16(9). e143–e147. 1 indexed citations
2.
Foster, Theresa, et al.. (2015). Expedited Programs for Serious Conditions: An Update on Breakthrough Therapy Designation. Clinical Therapeutics. 37(9). 2104–2120. 16 indexed citations
3.
Steinberg, Michael & Anna K. Morin. (2015). The Impact of Prematriculation Admission Characteristics on Graduation Rates in an Accelerated Doctor of Pharmacy Program. American Journal of Pharmaceutical Education. 79(8). 118–118. 8 indexed citations
4.
Tataronis, Gary, et al.. (2015). Use of vitamins, minerals, herbs, and supplements among pharmacy and nursing students: Why educators should consider factors influencing students’ choices. Currents in Pharmacy Teaching and Learning. 7(4). 427–433. 3 indexed citations
5.
Steinberg, Michael & M. R. Cooper. (2015). Impact of an oncology pharmacy elective course on guiding Doctor of Pharmacy students toward specializing in oncology pharmacy. Currents in Pharmacy Teaching and Learning. 7(5). 621–626. 2 indexed citations
6.
Steinberg, Michael, et al.. (2014). Assessment of Proper Medication Inhaler Technique in Adult Patients. Journal of Pharmacy Technology. 30(6). 195–200. 3 indexed citations
7.
Steinberg, Michael, et al.. (2013). Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia. OncoTargets and Therapy. 6. 1111–1111. 20 indexed citations
8.
Cooper, M. R., et al.. (2013). Vandetanib for the Treatment of Medullary Thyroid Carcinoma. Annals of Pharmacotherapy. 48(3). 387–394. 20 indexed citations
9.
Steinberg, Michael & Anna K. Morin. (2011). Academic Performance in a Pharmacotherapeutics Course Sequence Taught Synchronously on Two Campuses Using Distance Education Technology. American Journal of Pharmaceutical Education. 75(8). 150–150. 20 indexed citations
10.
Cooper, M. R., et al.. (2011). Single-Agent, Broad-Spectrum Fluoroquinolones for the Outpatient Treatment of Low-Risk Febrile Neutropenia. Annals of Pharmacotherapy. 45(9). 1094–1102. 5 indexed citations
11.
Melillo, Stephanie, et al.. (2011). Postdoctoral pharmacy industry fellowships: A descriptive analysis of programs and postgraduate positions. American Journal of Health-System Pharmacy. 69(1). 63–68. 8 indexed citations
12.
13.
Shaughnessy, Paul, Miguel Islas‐Ohlmayer, Janet E. Murphy, et al.. (2010). Plerixafor Plus G-CSF Resulted In Similar Cost But More Predictable Days Of Apheresis Compared To Chemotherapy Plus G-CSF For Mobilization Of Autologous Hematopoietic Stem Cells. Biology of Blood and Marrow Transplantation. 16(2). S203–S203. 1 indexed citations
14.
Melillo, Stephanie, et al.. (2010). Rivaroxaban for Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery. Annals of Pharmacotherapy. 44(6). 1061–1071. 11 indexed citations
15.
Cooper, M. R., et al.. (2009). Efficacy and Safety of Modafinil in the Treatment of Cancer-Related Fatigue. Annals of Pharmacotherapy. 43(4). 721–725. 27 indexed citations
16.
Shaughnessy, Paul, Miguel Islas‐Ohlmayer, Julie A. Murphy, et al.. (2009). Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.. Blood. 114(22). 2277–2277. 6 indexed citations
17.
Scanlon, James, et al.. (2009). Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis. Annals of Pharmacotherapy. 43(9). 1456–1465. 13 indexed citations
18.
Steinberg, Michael. (2008). Ixabepilone: A novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer. Clinical Therapeutics. 30(9). 1590–1617. 24 indexed citations
19.
20.
Steinberg, Michael & Anna K. Morin. (2006). Mild serotonin syndrome associated with concurrent linezolid and fluoxetine. American Journal of Health-System Pharmacy. 64(1). 59–62. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tusar Giri Breakdown of academic impact, for papers by David P. Sheridan Breakdown of academic impact, for papers by Eveline de Bont Breakdown of academic impact, for papers by Philip A. DeSimone Breakdown of academic impact, for papers by Wei‐Sheng Huang Breakdown of academic impact, for papers by Sarah S. Burns Breakdown of academic impact, for papers by Duncan R. Forsyth Breakdown of academic impact, for papers by Klára Gadó Breakdown of academic impact, for papers by Martin Vogelhuber Breakdown of academic impact, for papers by William Roberts
Rankless by CCL
2026